Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2074.1%
Neutral622.2%
Bearish13.7%
FN2 Earnings Intelligence
MSCI Inc. (MSCI) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 10, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 8, 2026 |
| UBS | Buy | Buy | Maintain | Apr 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Dec 18, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 12, 2024 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Oct 9, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 26, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Apr 24, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 9, 2024 |
| Redburn Partners | Neutral | Buy | Downgrade | Sep 14, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jul 17, 2023 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 8, 2020 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Feb 12, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 11, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 11, 2019 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 3, 2017 |
| Macquarie | Neutral | Neutral | Maintain | Feb 5, 2016 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Nov 10, 2015 |
| Keefe, Bruyette & Woods | Market Perform | Underperform | Upgrade | Nov 2, 2015 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Nov 2, 2015 |
| Janney Capital | Buy | Buy | Maintain | Dec 12, 2013 |
Upside is calculated against the persisted previous close $582.92. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $722 | $569.86 | +23.9% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $690 | $561.74 | +18.4% | Jul 22, 2026 |
| UBS | Analyst unavailable | $615 | $561.74 | +5.5% | Jul 22, 2026 |
| Morgan Stanley | Toni Kaplan | $700 | $561.74 | +20.1% | Jul 21, 2026 |
| Barclays | Manav Patnaik | $735 | $603.35 | +26.1% | Jul 10, 2026 |
| Raymond James | Patrick O'Shaughnessy | $760 | $597.24 | +30.4% | Jul 8, 2026 |
| Redburn Partners | Analyst unavailable | $690 | $596.89 | +18.4% | Jun 18, 2026 |
| Wells Fargo | Jason Hass | $700 | $588.52 | +20.1% | May 27, 2026 |
| Raymond James | Patrick O'Shaughnessy | $730 | $589.17 | +25.2% | Apr 21, 2026 |
| Deutsche Bank | Analyst unavailable | $715 | $605.47 | +22.7% | Jan 29, 2026 |
| Evercore ISI | David Motemaden | $690 | $607.3 | +18.4% | Jan 29, 2026 |
| RBC Capital | Ashish Sabadra | $655 | $604.54 | +12.4% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $618 | $614.87 | +6.0% | Jan 29, 2026 |
| UBS | Analyst unavailable | $638 | $614.87 | +9.4% | Jan 28, 2026 |
| Raymond James | Patrick O'Shaughnessy | $690 | $586.47 | +18.4% | Jan 12, 2026 |
| UBS | Analyst unavailable | $710 | $593.76 | +21.8% | Oct 29, 2025 |
| UBS | Analyst unavailable | $601 | $593.76 | +3.1% | Oct 29, 2025 |
| Barclays | Manav Patnaik | $660 | $593.76 | +13.2% | Oct 29, 2025 |
| Seaport Global | Analyst unavailable | $650 | $567.41 | +11.5% | Oct 1, 2025 |
| Goldman Sachs | George Tong | $723 | $597.9 | +24.0% | Dec 18, 2024 |
| Goldman Sachs | George Tong | $617 | $578.93 | +5.8% | Oct 30, 2024 |
| Morgan Stanley | Toni Kaplan | $662 | $578.93 | +13.6% | Oct 29, 2024 |
| Barclays | Manav Patnaik | $700 | $559.75 | +20.1% | Sep 13, 2024 |
| Wells Fargo | Jason Haas | $570 | $532.41 | -2.2% | Aug 12, 2024 |
| Argus Research | John Eade | $600 | $544.6 | +2.9% | Jul 26, 2024 |
| UBS | Alex Kramm | $585 | $493 | +0.4% | Jul 9, 2024 |
| RBC Capital | Ashish Sabadra | $638 | $498.31 | +9.4% | Jun 6, 2024 |
| Goldman Sachs | George Tong | $526 | $503.83 | -9.8% | May 23, 2024 |
| Deutsche Bank | Faiza Alwy | $569 | $468.5 | -2.4% | Apr 24, 2024 |
| J.P. Morgan | Analyst unavailable | $585 | $561.94 | +0.4% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $543 | $538.02 | -6.8% | Feb 1, 2023 |
| RBC Capital | Analyst unavailable | $600 | $537.72 | +2.9% | Feb 1, 2023 |
| Oppenheimer | Analyst unavailable | $575 | $532.18 | -1.4% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $549 | $531.56 | -5.8% | Feb 1, 2023 |
| Raymond James | Patrick O'Shaughnessy | $539 | $505.24 | -7.5% | Jan 15, 2023 |
| Morgan Stanley | Analyst unavailable | $518 | $473.58 | -11.1% | Jan 4, 2023 |
| J.P. Morgan | Analyst unavailable | $580 | $522.87 | -0.5% | Dec 13, 2022 |
| Barclays | Analyst unavailable | $600 | $521.39 | +2.9% | Dec 2, 2022 |
| RBC Capital | Ashish Sabadra | $520 | $429.78 | -10.8% | Jun 28, 2022 |
| Barclays | Manav Patnaik | $470 | $416.71 | -19.4% | Jun 24, 2022 |
| Deutsche Bank | Analyst unavailable | $477 | $420.22 | -18.2% | Apr 27, 2022 |
| Barclays | Analyst unavailable | $570 | $422.42 | -2.2% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $540 | $424.62 | -7.4% | Apr 27, 2022 |
Track every rating change on MSCI the moment it posts. Free to start.
Start free